According to a statement from the Robert Koch Institute (RKI) in Germany, the Permanent Vaccination Commission (STIKO) recommended that young people and children with certain diseases receive the BioNTech-Pfizer vaccine because of the possibility of severe COVID-19.
Emphasizing that the vaccine is not generally recommended for children and young people aged 12-17 who do not have any disease at the moment, it was emphasized that the vaccine can also be applied to this group, upon the request of the child and parent, after the doctor’s recommendation.
Specific diseases in question include obesity, various heart diseases, chronic lung and chronic kidney diseases, Down syndrome and diabetes, the statement said.
In a statement to the German News Agency (DPA), STIKO President Thomas Mertens stated that it is necessary to weigh the benefits and possible risks when making this decision, and stated that the risk of getting seriously ill with COVID-19 is low for 12-17 year olds.
Mertens shared the information that only 2 deaths occurred in this age group in Germany, and stated that both people had serious pre-illness.
The European Union’s drug regulator, the European Medicines Agency (EMA), approved the BioNTech-Pfizer vaccine to be administered to the 12-15 age group at the end of May.